Oksana Lukash - Avid Bioservices Vice People
| CDMODelisted Stock | USD 12.49 0.00 0.00% |
Executive
Oksana Lukash is Vice People of Avid Bioservices
| Phone | 714 508 6100 |
| Web | https://www.avidbio.com |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of (0.0305) % which means that it has lost $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1584) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities.Avid Bioservices currently holds 207.83 M in liabilities with Debt to Equity (D/E) ratio of 1.02, which is about average as compared to similar companies. Avid Bioservices has a current ratio of 1.89, which is within standard range for the sector. Note, when we think about Avid Bioservices' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MSc MD | AnaptysBio | N/A | |
| Benjamin Stone | AnaptysBio | N/A | |
| Robert Richard | Lyra Therapeutics | 67 | |
| Ami Knoefler | Adagene | N/A | |
| Minji MBA | Mineralys Therapeutics, Common | N/A | |
| David MD | Immunocore Holdings | 54 | |
| Jarrod Aldom | Kalvista Pharmaceuticals | N/A | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Monique Silva | AnaptysBio | N/A | |
| Robert MD | Lyra Therapeutics | N/A | |
| Jessica Ibbitson | Mineralys Therapeutics, Common | N/A | |
| John MBA | Dyne Therapeutics | 62 | |
| Jeffrey Fellows | Mineralys Therapeutics, Common | N/A | |
| JeanLuc Girardet | Mirum Pharmaceuticals | N/A | |
| Robert McKean | Mineralys Therapeutics, Common | N/A | |
| Tim Randall | MeiraGTx Holdings PLC | N/A | |
| Brian Piekos | Kalvista Pharmaceuticals | 50 | |
| Matt Yang | Cytokinetics | N/A | |
| Robert JD | MeiraGTx Holdings PLC | 49 | |
| Cindy Berejikian | Mineralys Therapeutics, Common | N/A | |
| Marc Wilson | Crinetics Pharmaceuticals | 45 | |
Management Performance
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0305 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, Chief Officer | ||
| Mark JD, General VP | ||
| Oksana Lukash, Vice People | ||
| Prof Brekken, Medical Advisor | ||
| Harold MD, Medical Advisor | ||
| Prof Schroit, Medical Advisor | ||
| Matthew Kwietniak, Chief Officer | ||
| Richard Richieri, Chief Officer | ||
| Tracy Kinjerski, VP Operations |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0305 | |||
| Profit Margin | (1.01) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 971.01 M | |||
| Shares Outstanding | 63.96 M | |||
| Shares Owned By Insiders | 1.13 % | |||
| Shares Owned By Institutions | 98.87 % | |||
| Number Of Shares Shorted | 11.62 M | |||
| Price To Earning | 10.76 X |
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving against Avid Stock
| 0.41 | SGD | Safe and Green | PairCorr |
| 0.39 | ASTI | Ascent Solar Technol | PairCorr |
| 0.36 | QLGN | Qualigen Therapeutics | PairCorr |
| 0.36 | MRK | Merck Company | PairCorr |
| 0.34 | COCXF | Chocoladefabriken Lindt | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |